Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVAC/PCa in Localized Prostate Cancer After Prostatectomy
NCT02107404Phase 2Completed
- Sponsor
- SOTIO Biotech
- Start
- Apr 2012
- Primary completion
- Jun 2015
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of stapuldencel in prostate cancer (PCa), sponsored by SOTIO Biotech. Started Apr 2012; status: completed.
02
Drugs
stapuldencel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02107404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107404.